CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

SF3B1 mutation / ring sideroblasts (MDS)

Gene: SF3B1 · Type: mutation

Indications: Myelodysplastic syndrome

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
LuspaterceptMyelodysplastic syndromeINDICATED
FDA Label
Label